When was Phil founded?

Phil was founded in 2015 and raised its 1st funding round within a year of its incorporation.

Where is Phil located?

Phil is headquartered in San Francisco, United States. It is registered at San Francisco, California.

How many employees does Phil have?

As of May 31, 2026, the latest employee count at Phil is 281.

Is Phil a funded company?

Phil is a funded company, having raised a total of $100M across 7 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Aug 13, 2015.

When was the latest funding round of Phil?

Phil's latest funding was a $***** Venture Debt round on Jul 08, 2025, with participation from 1 investor. Its primary sector is Pharmacy IT. In United States, the Pharmacy IT sector has seen $93.5M in funding in 2026 to date.

Where does Phil rank among its competitors?

Phil ranks 10th amongst 700 active competitors, of which 66 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Phil, which secured $60M in Jul, 2025.

Who are the top competitors of Phil?

Phil's top competitors include Omnicell, Alto and NimbleRx. Among them, Phil secured the most recent funding round in July, 2025.

Phil - 2026 Company Profile, Team, Funding & Competitors

Company Details

Technology-driven hub simplifying medication access and improving patient outcomes. They offer solutions to pharmaceutical manufacturers, patients, and providers, streamlining the prescription journey. Their platform focuses on maximizing patient access and adherence through a direct-to-patient approach. They provide a comprehensive solution for commercial success, leveraging a digital hub and technology to improve patient experience and drive brand performance. They offer advanced prior authorization processes, an integrated pharmacy network, and end-to-end visibility with data and insights. Their services include patient login, book demo, and a commitment to improving lives through technology. They are a B2B and B2C company offering SaaS and software solutions. They aim to create a social impact by improving patient health outcomes.

Website: phil.us
Email ID: *****@phil.us
Phone Number: +1 **********
Registered Address: San Francisco, California

Key Metrics

Founded Year

2015

Location

San Francisco, United States

Stage

Series D

Total Funding

$100M in 7 rounds

Latest Funding Round

Venture Debt, Jul 08, 2025, $*****

Investors

Crosslink Capital & 16 more

Ranked

10^th among 700 active competitors

Employee Count

281 as on May 31, 2026

Similar Companies

Omnicell & 4789 more

View Phil's full profile

Phil is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
PHIL INC. CIN: 474554128 , United States, Active	Dec 31, 1999	-	227 (As on Dec 31, 2024)	-
PHIL, INC. CIN: 32092664914 , United States, Active	Nov 29, 2023	-	-	-

Phil has raised a total funding of $100M over 7 rounds. Its first funding round was on Aug 13, 2015. Its latest funding round was a Venture Debt round on Jul 08, 2025 for $*****. 1 investor participated in its latest round. Phil has 17 institutional investors.

Here is the list of recent funding rounds of Phil:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 08, 2025	4581969	Venture Debt	2283442	9323041	7314580	6910688
Jun 03, 2021	8255323	Series D	2784925	6044228	8648387	5944940
May 15, 2019	8898500	Series B	1519504	2766282	GreatPoint Ventures	Tarsadia & 2 more

Access funding benchmarks and valuations. Sign up today!

View details of Phil's funding rounds and investors

Phil's Board of Directors

Phil's board has 1 active member. Deepak Thomas is independent board member.

Here is the list of Phil's board of directors:

Name	Type	Representing	Status	Duration
Deepak Thomas	Independent board member	-	Current	10y 11m

Phil's employee count trend

Phil has 281 employees as of May 26. Here is Phil's employee count trend over the years:

Uncover Phil's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Phil include Omnicell, Alto and NimbleRx. Here is the list of Top 10 competitors of Phil, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Omnicell 1992, Mountain View (United States), Public	Developer of automated dispensing system for pharmacies	$20M	ABS Capital, Ascension Ventures & 7 others	76/100
2nd	Alto 2015, San Francisco (United States), Acquired	Online pharmacy offering prescription delivery services	$592M	Greenoaks, SoftBank Vision Fund & 37 others	75/100
3rd	NimbleRx 2015, Palo Alto (United States), Acquired	Provider of digital pharmacy management software and prescription delivery services	$74.7M	Four Rivers Group, Y Combinator & 9 others	75/100
4th	Blink Health 2015, New York City (United States), Series B	Online pharmacy offering discounted prescription drugs	$165M	Princeville Capital, Scott Belsky & 10 others	75/100
5th	Proteus Digital Health 2001, Redwood City (United States), Series H	Provider of cloud-based patient medication adherence monitoring system for the healthcare providers	$532M	Adams Street Partners, Medtronic & 24 others	68/100
6th	Scene 2008, Brooklandville (United States), Series B	SaaS-based medication adherence platform for healthcare providers	$25.3M	Baltimore Angels, Kapor Capital & 14 others	67/100
7th	Thirty Madison 2017, New York City (United States), Acquired	Healthcare platform offers various brands and personalized treatments	$210M	Northzone, Maveron & 24 others	66/100
8th	Icebreaker Health 2014, San Francisco (United States), Acquired	Provider of remote patient consultation services and online delivery of medical care products	$64.7M	Hikma Ventures, OTV & 14 others	66/100
9th	MedMinder Systems 2008, Needham (United States), Acquired	Smart pill box for monitoring medication adherence	$62.7M	Accelmed, Trinnovate Ventures & 4 others	64/100
10th	Phil 2015, San Francisco (United States), Series D	Technology-driven hub simplifying medication access and improving patient outcomes	$100M	K2 HealthVentures, Crosslink Capital & 15 others	64/100